Article Details
Retrieved on: 2024-12-16 19:22:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Goldman Sachs Asset Management (GS) is nearing a more than EUR 2B deal to buy drugmaker Synthon from BC Partners, people familiar tell the Finan.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here